Etamzilat Tablets 250mg: A Comprehensive Guide to Hemostatic Treatment
Etamzilat tablets 250mg are a reliable and effective treatment option for a variety of bleeding conditions. This comprehensive guide provides detailed information on its uses, dosage, safety, and potential side effects.
Description:
Etamzilat is a synthetic hemostatic and angioprotective agent that works at the initial stage of hemostasis, promoting platelet adhesion and strengthening capillary walls. This helps reduce bleeding time and blood loss, effectively managing various bleeding episodes.
Key Features:
- Dosage: 250mg tablets, available in packs of 10×5.
- Action: Improves platelet adhesion and capillary resistance.
- Benefits: Reduces bleeding time and blood loss.
- Uses: Pre- and postoperative bleeding prevention, treatment of capillary bleeding, metrorrhagia, menorrhagia.
Indications for Use:
Surgery:
- Prevention and treatment of pre- and postoperative capillary bleeding in various surgical procedures.
Therapy:
- Prevention and treatment of capillary bleeding from diverse origins, including hematuria, intestinal bleeding, hematemesis, melena, epistaxis, and bleeding from the gums.
Gynecology:
- Metrorrhagia, primary menorrhagia, or menorrhagia caused by intrauterine contraceptives, excluding organic pathologies.
Dosage and Administration:
Adults and Adolescents (over 14 years old):
- Surgery: 1-2 tablets (250-500mg) one hour before surgery. After surgery: 1-2 tablets (250-500mg) every 4-6 hours as needed.
- Therapy: 2 tablets (500mg) 2-3 times daily (1000-1500mg) during meals.
- Gynecology: 2 tablets (500mg) 3 times daily (1500mg) during meals for 10 days, starting 5 days before expected menstruation.
Children under 14:
- Half the adult dose, not exceeding 3 tablets daily in three doses.
Special Considerations:
- Hepatic or Renal Insufficiency: Use with caution.
- Elderly Patients: Monitor renal and hepatic function.
- Pregnancy: Use only if absolutely necessary.
- Lactation: Not recommended.
- Missed Dose: Take the usual dose as soon as possible unless it’s nearly time for the next dose. Do not double the dose.
Precautions:
- Patients should be under medical supervision.
- Other causes of bleeding should be ruled out.
- Monitor hemostasis parameters.
- Exercise caution in patients with thrombosis, thromboembolism, anticoagulant overdose, renal insufficiency, and a history of bleeding.
Drug Interactions:
- Combination with aminocaproic acid and vikasol is acceptable.
- Laboratory tests should be performed before the first daily dose to avoid interference.
Contraindications:
- Hypersensitivity to etamsylate or any excipients.
- Acute porphyria.
- Increased blood clotting, thrombosis, thromboembolism.
- Hemoblastosis in children.
- Children under 6 years old.
Side Effects:
- Gastrointestinal disorders: Nausea, diarrhea, abdominal discomfort.
- Skin and subcutaneous tissue disorders: Rash.
- General disorders: Asthenia, fever.
- Nervous system disorders: Headache.
- Vascular disorders: Thromboembolism (very rare).
- Blood and lymphatic system disorders: Agranulocytosis, neutropenia, thrombocytopenia (very rare).
- Musculoskeletal and connective tissue disorders: Arthralgia (rare).
- Immune system disorders: Hypersensitivity (very rare).
- Metabolic disorders: Acute porphyria (very rare).
Overdose:
No specific information available. Treatment is symptomatic.
Storage:
Store in a cool, dry place protected from light, below 25°C. Keep out of reach of children.
Note: This information is for general knowledge and should not replace professional medical advice. Consult your doctor for diagnosis, treatment, and individualized advice.
Buy Etamzilat Tablets 250mg No. 10×5:
For purchasing Etamzilat tablets 250mg No. 10×5, please contact your local pharmacy or healthcare provider.